技术与方法 |
|
|
|
|
基于深度学习与多层次信息融合的药物靶标亲和力预测* |
唐跃威1,刘治平1,2,**() |
1 山东大学控制科学与工程学院 济南 250061 2 山东大学智能医学工程研究中心 济南 250061 |
|
Drug-target Affinity Prediction Based on Deep Learning and Multi-layered Information Fusion |
TANG Yue-wei1,LIU Zhi-ping1,2,**() |
1 School of Control Science and Engineering, Shandong University, Jinan 250061, China 2 Center for Intelligent Medicine, Shandong University, Jinan 250061, China |
[1] |
Mullard A. New drugs cost US$2.6 billion to develop. Nature Reviews Drug Discovery, 2014, 13(12):877.
|
[2] |
Ashburn T T, Thor K B. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery, 2004, 3(8):673-683.
pmid: 15286734
|
[3] |
Öztürk H, Ozkirimli E, Özgür A. WideDTA: prediction of drug-target binding affinity.[2019-02-04].https://arxiv.org/abs/1902.04166 .
|
[4] |
Yamanishi Y, Kotera M, Kanehisa M, et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics, 2010, 26(12):i246-i254.
doi: 10.1093/bioinformatics/btq176
|
[5] |
Nascimento A C A, Prudêncio R B C, Costa I G. A multiple kernel learning algorithm for drug-target interaction prediction. BMC Bioinformatics, 2016, 17:46.
doi: 10.1186/s12859-016-0890-3
pmid: 26801218
|
[6] |
Cheng Z Z, Zhou S G, Wang Y, et al. Effectively identifying compound-protein interactions by learning from positive and unlabeled examples. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2018, 15(6):1832-1843.
doi: 10.1109/TCBB.8857
|
[7] |
Pahikkala T, Airola A, Pietilä S, et al. Toward more realistic drug-target interaction predictions. Briefings in Bioinformatics, 2015, 16(2):325-337.
doi: 10.1093/bib/bbu010
pmid: 24723570
|
[8] |
He T, Heidemeyer M, Ban F Q, et al. SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines. Journal of Cheminformatics, 2017, 9(1):24.
doi: 10.1186/s13321-017-0209-z
|
[9] |
Wu Y F, Gao M, Zeng M, et al. BridgeDPI: a novel graph neural network for predicting drug-protein interactions.[2021-01-29].https://arxiv.org/abs/2101.12547 .
|
[10] |
Hinton G, Deng L, Yu D, et al. Deep neural networks for acoustic modeling in speech recognition: the shared views of four research groups. IEEE Signal Processing Magazine, 2012, 29(6):82-97.
|
[11] |
Ma J S, Sheridan R P, Liaw A, et al. Deep neural nets as a method for quantitative structure-activity relationships. Journal of Chemical Information and Modeling, 2015, 55(2):263-274.
doi: 10.1021/ci500747n
|
[12] |
Öztürk H, Özgür A, Ozkirimli E. DeepDTA: deep drug-target binding affinity prediction. Bioinformatics, 2018, 34(17):i821-i829.
doi: 10.1093/bioinformatics/bty593
|
[13] |
Abbasi K, Razzaghi P, Poso A, et al. DeepCDA: deep cross-domain compound-protein affinity prediction through LSTM and convolutional neural networks. Bioinformatics, 2020, 36(17):4633-4642.
doi: 10.1093/bioinformatics/btaa544
|
[14] |
Hirohara M, Saito Y, Koda Y, et al. Convolutional neural network based on SMILES representation of compounds for detecting chemical motif. BMC Bioinformatics, 2018, 19(Suppl 19):526.
doi: 10.1186/s12859-018-2523-5
pmid: 30598075
|
[15] |
Karimi M, Wu D, Wang Z Y, et al. DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks. Bioinformatics, 2019, 35(18):3329-3338.
doi: 10.1093/bioinformatics/btz111
|
[16] |
Lim J, Ryu S, Park K, et al. Predicting drug-target interaction using a novel graph neural network with 3D structure-embedded graph representation. Journal of Chemical Information and Modeling, 2019, 59(9):3981-3988.
doi: 10.1021/acs.jcim.9b00387
|
[17] |
Gomes J, Ramsundar B, Feinberg E N, et al. Atomic convolutional networks for predicting protein-ligand binding affinity.[2017-03-30].https://arxiv.org/abs/1703.10603 .
|
[18] |
Rose P W, Prlić A, Altunkaya A, et al. The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Research, 2017, 45(D1):D271-D281.
|
[19] |
Davis M I, Hunt J P, Herrgard S, et al. Comprehensive analysis of kinase inhibitor selectivity. Nature Biotechnology, 2011, 29(11):1046-1051.
doi: 10.1038/nbt.1990
|
[20] |
Tang J, Szwajda A, Shakyawar S, et al. Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis. Journal of Chemical Information and Modeling, 2014, 54(3):735-743.
doi: 10.1021/ci400709d
|
[21] |
Rogers D, Hahn M. Extended-connectivity fingerprints. Journal of Chemical Information and Modeling, 2010, 50(5):742-754.
doi: 10.1021/ci100050t
pmid: 20426451
|
[22] |
Wu Z H, Pan S R, Chen F W, et al. A comprehensive survey on graph neural networks. IEEE Transactions on Neural Networks and Learning Systems, 2021, 32(1):4-24.
doi: 10.1109/TNNLS.5962385
|
[23] |
Ramsundar B, Eastman P, Walters P, et al. Deep learning for the life sciences: applying deep learning to genomics, microscopy, drug discovery, and more. California: O’Reilly Media, 2019: 55-56.
|
[24] |
Kipf T N, Welling M. Semi-supervised classification with graph convolutional networks.[2017-02-22].https://arxiv.org/abs/1609.02907v4 .
|
[25] |
Gönen M, Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika, 2005, 92(4):965-970.
doi: 10.1093/biomet/92.4.965
|
[26] |
Sigrist C J A, Cerutti L, de Castro E, et al. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Research, 2010, 38(suppl_1):D161-D166.
doi: 10.1093/nar/gkp885
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|